Cas:136033-55-1 Isoastragaloside IV manufacturer & supplier

We serve Chemical Name:Isoastragaloside IV CAS:136033-55-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Isoastragaloside IV

Chemical Name:Isoastragaloside IV
CAS.NO:136033-55-1
Synonyms:Isoastragaloside IV
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Isoastragaloside IV chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Isoastragaloside IV physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Isoastragaloside IV Use and application,Isoastragaloside IV technical grade,usp/ep/jp grade.


Related News: The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China. Isoastragaloside IV manufacturer The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. Isoastragaloside IV supplier The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China. Isoastragaloside IV vendor The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China. Isoastragaloside IV factory Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.